Institutional Ownership Pharma Cyte Biotech, Inc. (PMCB)
This table provides information about the institutional ownership of Pharma Cyte Biotech, Inc. (PMCB). We have compiled data on the 27 institutions that hold shares in the stock, with a total of 706,247 shares, which have been reported (via 13F filing form) to have a value of $1.17 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
192,387
shares
|
$319,362
0.0% of portfolio
|
Q2 2024
Added 10.19%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
164,736
shares
|
$273,461
0.0% of portfolio
|
Q4 2024
Reduced 2.06%
|
|
Ayrton Capital LLC
Westport, CT |
Nov 13, 2023 Q3 2023 |
92,087
shares
|
$152,864
7.31% of portfolio
|
Q3 2023
Reduced 66.75%
|
|
Equitec Proprietary Markets, LLC
|
Jan 29, 2025 Q4 2024 |
82,727
shares
|
$137,326
0.07% of portfolio
|
Q3 2023
Added 34.7%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
49,300
shares
|
$81,838
0.0% of portfolio
|
Q4 2024
Reduced 0.8%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Feb 14, 2025 Q4 2024 |
34,481
shares
|
$57,238
0.0% of portfolio
|
Q4 2024
Reduced 2.12%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
26,841
shares
|
$44,556
0.0% of portfolio
|
Q4 2024
Reduced 2.75%
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
25,700
shares
|
$42,662
0.0% of portfolio
|
Q4 2024
Reduced 0.77%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
19,208
shares
|
$31,885
0.0% of portfolio
|
Q2 2024
Reduced 0.11%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
13,346
shares
|
$22,154
0.0% of portfolio
|
Q2 2024
Reduced 36.76%
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Feb 13, 2025 Q4 2024 |
2,445
shares
|
$4,058
0.0% of portfolio
|
Q4 2024
Reduced 14.51%
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
1,874
shares
|
$3,110
0.0% of portfolio
|
Q4 2024
Reduced 77.57%
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Feb 07, 2025 Q4 2024 |
508
shares
|
$843
0.0% of portfolio
|
Q3 2024
Reduced 0.97%
|
|
Covestor LTD
Boston, MA |
Feb 13, 2025 Q4 2024 |
275
shares
|
$456
0.0% of portfolio
|
Q4 2024
Added 21.68%
|
|
Planning Capital Management Corp
Paoli, PA |
Nov 06, 2024 Q3 2024 |
100
shares
|
$166
0.0% of portfolio
|
Q2 2024
New holding
|
|
Royal Bank Of Canada
Toronto, A6 |
Feb 14, 2025 Q4 2024 |
98
shares
|
$162
0.0% of portfolio
|
Q4 2024
Reduced 2.0%
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
78
shares
|
$129
0.0% of portfolio
|
Q4 2024
Reduced 33.33%
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
18
shares
|
$29
0.0% of portfolio
|
Q3 2024
Reduced 5.26%
|
|
Highlander Capital Management, LLC
Short Hills, NJ |
May 20, 2024 Q1 2024 |
14
shares
|
$23
0.0% of portfolio
|
Q3 2023
New holding
|
|
Sachetta, LLC
Lynnfield, MA |
Jan 21, 2025 Q4 2024 |
14
shares
|
$23
0.0% of portfolio
|
Q4 2023
New holding
|
|
Bfsg, LLC
|
Jan 31, 2025 Q4 2024 |
5
shares
|
$8
0.0% of portfolio
|
Q2 2024
Reduced 28.57%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
2
shares
|
$3
0.0% of portfolio
|
Q3 2024
Reduced 33.33%
|
|
New Edge Advisors, LLC
New Orleans, LA |
Feb 13, 2025 Q4 2024 |
2
shares
|
$3
0.0% of portfolio
|
Q2 2024
Reduced 33.33%
|
|
Cwm, LLC
|
Feb 04, 2025 Q4 2024 |
1
shares
|
$1
0.0% of portfolio
|
Q2 2024
Reduced 99.9%
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Feb 13, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|